Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Prices $750M in Senior Notes

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies said last night that it has priced two series of senior notes offerings with an aggregate principal amount of $750 million.

The first series of $250 million in 2.5 percent notes will mature in July 2013. The second series of $500 million in 5 percent notes will mature in July 2020.

Agilent expects to close the offering on July 20.

The firm will use the proceeds to satisfy, in part, the financing obligation of Agilent Technologies World Trade, the subsidiary that acquired Varian for $1.5 billion in May.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.